Autobio Diagnostics Co Ltd - Class A

SHSE:603658 (China)   Class A
Â¥ 51.29 (-1%) May 31
22.95
P/B:
3.43
Market Cap:
Â¥ 30.07B ($ 4.15B)
Enterprise V:
Â¥ 29.24B ($ 4.04B)
Volume:
3.36M
Avg Vol (2M):
4.71M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Autobio Diagnostics Co Ltd ( SHSE:603658 ) from 2016 to Jun 01 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Autobio Diagnostics stock (SHSE:603658) PE ratio as of Jun 01 2024 is 22.95. More Details

Autobio Diagnostics Co Ltd (SHSE:603658) PE Ratio (TTM) Chart

To

Autobio Diagnostics Co Ltd (SHSE:603658) PE Ratio (TTM) Historical Data

Total 1199
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Autobio Diagnostics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-01 22.9 2024-03-26 28.4
2024-05-31 22.9 2024-03-25 28.6
2024-05-30 23.1 2024-03-22 28.8
2024-05-29 22.9 2024-03-21 28.6
2024-05-28 22.7 2024-03-20 29.0
2024-05-27 22.8 2024-03-19 29.0
2024-05-24 23.0 2024-03-18 29.8
2024-05-23 22.9 2024-03-15 29.5
2024-05-22 23.1 2024-03-14 30.1
2024-05-21 23.6 2024-03-13 29.7
2024-05-20 23.6 2024-03-12 29.9
2024-05-17 23.4 2024-03-11 30.2
2024-05-16 23.6 2024-03-08 29.2
2024-05-15 23.9 2024-03-07 29.1
2024-05-14 24.2 2024-03-06 30.1
2024-05-13 24.3 2024-03-05 30.4
2024-05-10 24.9 2024-03-04 30.1
2024-05-09 25.4 2024-03-01 30.5
2024-05-08 25.3 2024-02-29 31.6
2024-05-07 25.7 2024-02-28 29.8
2024-05-06 26.0 2024-02-27 28.4
2024-04-30 25.5 2024-02-26 28.6
2024-04-29 25.7 2024-02-23 27.9
2024-04-26 25.2 2024-02-22 27.8
2024-04-25 25.1 2024-02-21 27.2
2024-04-24 25.7 2024-02-20 27.2
2024-04-23 25.1 2024-02-19 26.5
2024-04-22 24.8 2024-02-16 25.9
2024-04-19 24.2 2024-02-09 25.9
2024-04-18 23.8 2024-02-08 25.9
2024-04-17 23.5 2024-02-07 27.1
2024-04-16 23.8 2024-02-06 26.0
2024-04-15 24.0 2024-02-05 23.6
2024-04-12 24.1 2024-02-02 23.7
2024-04-11 24.4 2024-02-01 22.7
2024-04-10 24.6 2024-01-31 22.4
2024-04-09 24.9 2024-01-30 22.9
2024-04-08 24.0 2024-01-29 22.0
2024-04-05 24.5 2024-01-26 22.5
2024-04-03 24.5 2024-01-25 22.7
2024-04-02 25.2 2024-01-24 22.2
2024-04-01 25.8 2024-01-23 22.4
2024-03-29 25.4 2024-01-22 22.4
2024-03-28 25.4 2024-01-19 23.7
2024-03-27 27.9 2024-01-18 24.1

Autobio Diagnostics Co Ltd (SHSE:603658) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.